Biophysical and Functional Characterization of Rhesus Macaque IgG Subclasses
View/ Open
Author
Boesch, Austin W.
Osei-Owusu, Nana Yaw
Crowley, Andrew R.
Chu, Thach H.
Chan, Ying N.
Weiner, Joshua A.
Bharadwaj, Pranay
Hards, Rufus
Adamo, Mark E.
Gerber, Scott A.
Cocklin, Sarah L.
Schmitz, Joern E.
Miles, Adam R.
Eckman, Joshua W.
Belli, Aaron J.
Reimann, Keith A.
Ackerman, Margaret E.
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.3389/fimmu.2016.00589Metadata
Show full item recordCitation
Boesch, A. W., N. Y. Osei-Owusu, A. R. Crowley, T. H. Chu, Y. N. Chan, J. A. Weiner, P. Bharadwaj, et al. 2016. “Biophysical and Functional Characterization of Rhesus Macaque IgG Subclasses.” Frontiers in Immunology 7 (1): 589. doi:10.3389/fimmu.2016.00589. http://dx.doi.org/10.3389/fimmu.2016.00589.Abstract
Antibodies raised in Indian rhesus macaques [Macaca mulatta (MM)] in many preclinical vaccine studies are often evaluated in vitro for titer, antigen-recognition breadth, neutralization potency, and/or effector function, and in vivo for potential associations with protection. However, despite reliance on this key animal model in translation of promising candidate vaccines for evaluation in first in man studies, little is known about the properties of MM immunoglobulin G (IgG) subclasses and how they may compare to human IgG subclasses. Here, we evaluate the binding of MM IgG1, IgG2, IgG3, and IgG4 to human Fc gamma receptors (FcγR) and their ability to elicit the effector functions of human FcγR-bearing cells, and unlike in humans, find a notable absence of subclasses with dramatically silent Fc regions. Biophysical, in vitro, and in vivo characterization revealed MM IgG1 exhibited the greatest effector function activity followed by IgG2 and then IgG3/4. These findings in rhesus are in contrast with the canonical understanding that IgG1 and IgG3 dominate effector function in humans, indicating that subclass-switching profiles observed in rhesus studies may not strictly recapitulate those observed in human vaccine studies.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153528/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:29739061
Collections
- HMS Scholarly Articles [17917]
Contact administrator regarding this item (to report mistakes or request changes)